Effectiveness of Ixekizumab in psoriasis patients previously treated with other IL-17 pathway inhibitors

被引：0
|
作者：
Chlinos, Antonios [1 ]
Beka, Panagiota [1 ]
Papoutsaki, Marina [1 ]
Panagakis, Panteleimon [1 ]
机构：
[1] Andreas Sygros Hosp Cutaneous & Venereal Dis, Athens, Greece
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB154 / AB154
页数：1
相关论文
共 50 条
  • [41] Anti-drug antibodies of IL-17 inhibitors for psoriasis: a systematic review
    Norden, Alexandra
    Oulee, Aislyn
    Munawar, Leena
    Javadi, Sogol Stephanie
    Han, George
    Wu, Jashin J.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (08) : 3080 - 3085
  • [42] Systematic review of anti-drug antibodies of IL-17 inhibitors for psoriasis
    Thomas, Logan W.
    Lee, Erica B.
    Wu, Jashin J.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (02) : 110 - 116
  • [43] Durable remissions of guttate psoriasis following short courses of IL-17 inhibitors
    Printy, Rachel
    Rivera-Oyola, Ryan
    Czernik, Annette
    Lebwohl, Mark
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (09) : 1161 - 1162
  • [44] Interleukin (IL)-19 is a novel component of the pathogenetic IL-23/IL-17 pathway in psoriasis
    Witte, E.
    Kokolakis, G.
    Witte, K.
    Philipp, S.
    Babel, N.
    Wittig, B. M.
    Erdmann-Keding, M.
    Kadin, M. E.
    Volk, H. -D.
    Sterry, W.
    Wolk, K.
    Sabat, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E155 - E155
  • [45] Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly
    Sofie Mylle
    Lynda Grine
    Reinhart Speeckaert
    Jo L.W. Lambert
    Nanja van Geel
    American Journal of Clinical Dermatology, 2018, 19 : 625 - 637
  • [46] The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
    Brembilla, Nicolo Costantino
    Senra, Luisa
    Boehncke, Wolf-Henning
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [47] Three cases of facial erythema with dryness and pruritus in psoriasis patients during treatment with IL-17 inhibitors
    Oiwa, T.
    Honda, T.
    Otsuka, A.
    Kabashima, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (04) : E122 - E123
  • [48] Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly
    Mylle, Sofie
    Grine, Lynda
    Speeckaert, Reinhart
    Lambert, Jo L. W.
    van Geel, Nanja
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (05) : 625 - 637
  • [49] Ixekizumab (Taltz) - A Second IL-17A Inhibitor for Psoriasis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1494): : 59 - 60
  • [50] Role of IL-17 in Psoriasis and Psoriatic Arthritis
    Raychaudhuri, Siba P.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2013, 44 (02) : 183 - 193
12345